MULTIINSTITUTION STUDY OF NON-HODGKINS LYMPHOMAS USING FROZEN SECTION IMMUNOPEROXIDASE - THE SOUTHEASTERN CANCER STUDY-GROUP EXPERIENCE

Authors:
  • MBMJ BOROWITZ
    MJ BOROWITZ
  • SNS NEWBY
    S NEWBY
  • RBRK BRYNES
    RK BRYNES
  • JCJB COUSAR
    JB COUSAR
  • CWCC WHITCOMB
    CC WHITCOMB
  • JCJD CRISSMAN
    JD CRISSMAN
  • GBGE BYRNE
    GE BYRNE
  • RCRD COLLINS
    RD COLLINS

  • 1 January 1984
    • journal article
    • research article
    • Vol. 63  (5) , 1147-1152
    • PMID:6370333
Abstract
The experience of the Southeastern Cancer Study Group (SECSG) with a transport medium used for immunologic phenotyping of non-Hodgkin''s lymphomas is described. In a 2-mo. pilot study, portions of 53 specimens of non-Hodgkin''s lymphoma from 4 member institutions of the SECSG and affiliated community hospitals were sent by regular mail to a central laboratory. Immunologic phenotyping was carried out using a frozen section immunoperoxidase technique. In 48 of the cases, a clear-cut immunologic phenotype was obtained. Tumors (34) were of B cell origin and 7 had T cell markers. Six of the remaining lymphomas had neither B nor T cell markers, and the 7th had both. In 12 cases, phenotyping was also carried out at the originating institution using conventional cell suspension techniques; agreement between the 2 methods was excellent. The immunologic results were correlated with histopathologic diagnosis standardized using the Working Formulation for non-Hodgkin''s lymphomas. The low grade tumors were all B cell, but the intermediate grade tumors were very heterogeneous immunologically. About 1/4 of the diffuse, intermediate grade or miscellaneous tumors had T cell markers. Immunologic phenotyping may be performed satisfactorily on transported material, making multiinstitution studies on the prognostic significance of immunologic phenotype in non-Hodgkin''s lymphomas feasible.